HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lawrence A Yannuzzi Selected Research

Acute zonal occult outer retinopathy

1/2018Clinical course of acute zonal occult outer retinopathy complicated by choroidal neovascularization.
7/2013Long-term follow-up of acute zonal occult outer retinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lawrence A Yannuzzi Research Topics

Disease

28Macular Degeneration (Age-Related Maculopathy)
01/2022 - 02/2002
23Choroidal Neovascularization
04/2019 - 02/2002
18Central Serous Chorioretinopathy
10/2021 - 01/2002
14Telangiectasis (Telangiectasia)
01/2022 - 06/2005
11Macular Edema
05/2021 - 06/2005
11Hemorrhage
03/2021 - 01/2004
11Atrophy
01/2019 - 01/2002
10Polypoidal Choroidal Vasculopathy
12/2016 - 08/2002
9Multifocal Choroiditis
03/2022 - 10/2002
8Retinal Detachment (Retinal Detachments)
01/2022 - 06/2002
8Ischemia
11/2020 - 08/2007
7Disease Progression
01/2018 - 08/2007
5Inflammation (Inflammations)
10/2016 - 06/2005
5Retinitis Pigmentosa (Pigmentary Retinopathy)
09/2014 - 01/2009
5Aneurysm (Aneurysms)
01/2012 - 08/2007
5Retinal Vein Occlusion
01/2012 - 03/2006
4White Dot Syndromes
01/2022 - 04/2006
4Neoplasms (Cancer)
04/2019 - 01/2011
4Retinal Telangiectasis
10/2018 - 06/2005
4Epiretinal Membrane (Epiretinal Membranes)
12/2017 - 03/2008
4Vascular Diseases (Vascular Disease)
11/2016 - 04/2007
3Myopia
11/2022 - 12/2017
3Cysts
12/2017 - 07/2015
3Edema (Dropsy)
04/2014 - 04/2006
3Vitreous Hemorrhage
01/2011 - 01/2008
2Vision Disorders (Hemeralopia)
10/2020 - 01/2008
2Retinitis
01/2020 - 08/2007
2Retinal Artery Occlusion
01/2020 - 01/2010
2Retinal Perforations
01/2020 - 01/2018
2Arterial Occlusive Diseases (Arterial Occlusive Disease)
11/2018 - 01/2015
2Acute zonal occult outer retinopathy
01/2018 - 07/2013
2Retinoschisis (Retinoschisis, Juvenile)
12/2017 - 07/2014
2Hyperplasia
12/2017 - 12/2009
2Diabetic Retinopathy (Retinopathy, Diabetic)
09/2016 - 09/2006
2Hamartoma
01/2015 - 01/2011
2Vitelliform Macular Dystrophy
01/2012 - 06/2004
2Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome)
05/2010 - 09/2007
2Angioid Streaks
05/2010 - 09/2007
2Infarction (Infarctions)
01/2008 - 08/2005
2Vasculitis (Vasculitides)
08/2007 - 06/2005
1Retinal Diseases
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Stroke (Strokes)
01/2022
1Arteritis
11/2021
1Congenital Abnormalities (Deformity)
05/2021
1Hemangioma (Angioma)
05/2021
1Hypopigmentation (Hypomelanosis)
03/2021
1Amenorrhea
03/2021
1Cerebellar Ataxia (Dysmetria)
03/2021
1Wounds and Injuries (Trauma)
12/2020
1Retinal Hemorrhage
11/2020
1Wyburn Mason's syndrome
01/2020
1Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)
01/2020
1Chorioretinitis
09/2019
1Calciphylaxis
11/2018
1Choroidal Effusions
12/2017
1Melanoma (Melanoma, Malignant)
12/2017
1Retinal Neoplasms
12/2017
1Microaneurysm
12/2017
1Renal Insufficiency (Renal Failure)
11/2017
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
11/2017
1Paraproteinemias (Monoclonal Gammopathy)
11/2017

Drug/Important Bio-Agent (IBA)

71Retinaldehyde (Retinal)IBA
01/2022 - 06/2002
38Fluorescein (Funduscein)FDA LinkGeneric
01/2022 - 01/2002
13Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2022 - 08/2002
9Bevacizumab (Avastin)FDA Link
01/2013 - 03/2006
8Retinal Pigments (Pigments, Visual)IBA
12/2017 - 12/2005
8Verteporfin (Visudyne)FDA Link
02/2012 - 02/2002
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2022 - 04/2007
7LipidsIBA
01/2022 - 08/2002
7Ranibizumab (Lucentis)FDA Link
05/2011 - 09/2007
51-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2018 - 10/2002
4Fluconazole (Zonal)FDA LinkGeneric
04/2017 - 07/2013
3Adrenal Cortex Hormones (Corticosteroids)IBA
04/2021 - 10/2002
3Triamcinolone (Aristocort)FDA Link
01/2010 - 06/2005
2Complement Factor H (Factor H)IBA
11/2008 - 05/2005
2Complement System Proteins (Complement)IBA
01/2008 - 05/2005
2anecortave acetateIBA
09/2006 - 09/2006
1Immunoglobulin G (IgG)IBA
01/2022
1SDDSIBA
01/2022
1HDL LipoproteinsIBA
01/2022
1AntibodiesIBA
01/2022
1Salivary alpha-AmylasesIBA
10/2021
1GlucocorticoidsIBA
04/2021
1Biomarkers (Surrogate Marker)IBA
11/2020
1CholesterolIBA
03/2020
1MicronutrientsIBA
01/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2017
1afliberceptIBA
12/2017
1NivolumabIBA
12/2017
1IpilimumabIBA
12/2017

Therapy/Procedure

15Photochemotherapy (Photodynamic Therapy)
01/2018 - 02/2002
10Therapeutics
01/2020 - 02/2002
8Intravitreal Injections
03/2022 - 03/2006
7Traction
11/2022 - 03/2008
5Lasers (Laser)
12/2020 - 08/2007
3Light Coagulation
02/2012 - 08/2007
3Injections
05/2010 - 09/2007
1Vitreoretinal Surgery
01/2022
1Trabeculectomy (Trabeculoplasty)
12/2020